Pharmaceutical company AstraZeneca has offered up to $1.265 billion to acquire TeneoTwo and the biotech company’s lymphoma research currently in a phase 1 trial.
Read the full post on Becker's Hospital Review - Healthcare News
AstraZeneca to shell out $1.27B for biotech company TeneoTwo
